| Revenue from operations | 77.83a | 68.93a |
| Other income | 0.67a | 0.38a |
| Total income | 78.5a | 69.31a |
| Expenses | — | — |
| Purchases of medical consumable and drugs | -18.38a | -16.03a |
| Changes in inventories of medical consumable and drugs | -0.08a | -0.15a |
| Employee benefits expense | -11.67a | -11.2a |
| Finance costs | -1.84a | -1.31a |
| Depreciation and amortisation expense | -3.86a | -3.42a |
| Other expenses | -31.97a | -28.87a |
| Total expenses | -67.65a | -60.99a |
| Profit from continuing operations before share of profit of equity accounted investees and tax | 10.85a | 8.32a |
| Share of profit of equity accounted investees (net of tax) | 0.12a | 0.1a |
| Profit before exceptional item and tax | 10.96a | 8.42a |
| Exceptional (loss)/gain | -0.89a | 0.16a |
| Profit before tax | 10.07a | 8.58a |
| Tax expense | — | — |
| Current tax | -1.82a | -1.67a |
| Deferred tax charge (net) | -0.15a | -0.46a |
| Total tax expense | -1.98a | -2.13a |
| Profit for the year | 8.09a | 6.45a |
| Profit for the year attributable to | — | — |
| Owners of the company | 7.74a | 5.99a |
| Non-controlling interests | 0.35a | 0.46a |